Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 218
Number of items: 218
  • van Nieuw Amerongen, A., Roukema, P. A., Vissink, A., & Veerman, E. C. I. (2000). The historical development of salivary research in the Netherlands. Journal of Dental Research, 79, 1928-1932.
  • van Nieuw Amerongen, A. (1999). Chronisch droge mond: nieuw speekselsubstituut: Xialine. CHRON INFLAMM BINDW TIJDSCHR, 7, 38.
  • Blankenvoorde, M. F. J. (1999). Salivary proteinase inhibitors and periodontitis: Cystatins in the defense against Porphyromonas gingivalis. [Thesis, fully external, Vrije Universiteit].
  • Helmerhorst, E. J. (1999). Design and characterization of antimicrobial peptides based on salivary histatins. [Thesis, fully external, Vrije Universiteit].
  • Bolscher, J. G. M., Groenink, J., van der Kwaak, J. S., van den Keijbus, P. A. M., van 't Hof, W., Veerman, E. C. I., & van Nieuw Amerongen, A. (1999). Detection and quantification of MUC7 in submandibular, sublingual, palatine and labial saliva by anti-peptide antiserum. Journal of Dental Research, 78, 1362-1369. https://doi.org/10.1177/00220345990780071101
  • van Nieuw Amerongen, A. (1999). Speeksel en gebitselementen. Coutinho.
  • van Nieuw Amerongen, A. (1999). Invloed van speeksel als interne risicofactor op erosie bij kinderen. In Erosie bij de jeugd. 't Is zuur voor het glazuur (pp. 13-18). Bohn, Stafleu,Van Loghum.
  • Groenink, J., Walgreen-Weterings, E., van 't Hof, W., Veerman, E. C. I., & van Nieuw Amerongen, A. (1999). Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiology Letters, 179, 217-222. https://doi.org/10.1111/j.1574-6968.1999.tb08730.x
  • Groenink, J., Walgreen-Weterings, E., Nazmi, K., Bolscher, J. G. M., Veerman, E. C. I., van Winkelhoff, A. J., & van Nieuw Amerongen, A. (1999). Salivary lactoferrin and low-Mr MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. Journal of Clinical Periodontology, 26, 269-275. https://doi.org/10.1034/j.1600-051X.1999.260501.x
  • Helmerhorst, E. J., Reijnders, I. M., van 't Hof, W., Simoons-Smit, I., Veerman, E. C. I., & van Nieuw Amerongen, A. (1999). Amphotericin B- and fluconazole-resistant Candida spp. , Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrobial Agents and Chemotherapy, 43, 702-704.
Page 18 of 22